VANI: Vivani Medical, Inc. Forward P/E Multiple

Graphic logo of vivani.com (VANI)

Vivani Medical, Inc. (VANI) develops Medidur subcutaneous systems for the long-term treatment of diabetes and obesity, replacing daily injections. The company's forward P/E ratio reflects the asset's valuation trend, with the latest reading standing at 0.00. While its proprietary platform provides a technological edge, geopolitical tensions and sanctions complicate international logistics and the execution of clinical trials.

Vivani Medical, Inc. - VANI Price to Expected Earnings Ratio (period 04/28/2023 - 11/16/2026)

Vivani Medical (VANI) - metric breakdowns and financial figures

- stock value and consensus price forecast:
Fundamental valuation:VANI Vivani Medical, Inc.
Brand item of vivani.com

For Vivani Medical, Inc. (VANI), which develops implants for the prolonged delivery of GLP-1, the ratio of current market capitalization to projected net income reflects market expectations regarding the commercialization of diabetes treatment technologies. By analyzing the changes in the company's expected P/E, an investor assesses the premium for future growth, where a high multiple confirms the market's belief in the product's clinical superiority and the long-term sustainability of investment capital.

Competitors of Vivani Medical, Inc.

Forward P/E Multiple BSX|EW: Price to Expected Earnings Ratio|ResMed Corp - Projected Price to Earnings|Market Cap to Projected Earnings Insulet (PODD)|zimmerbiomet.com - Forward P/E Multiple|Projected Price to Earnings Ratio CooperCompanies|ALGN: Forward P/E Multiple|Projected Price to Earnings Ratio Globus Medical Corp (GMED)|TMDX (TransMedics Group Inc) - Forward P/E Multiple|Price to Future Earnings Ratio ATEC (Alphatec)|Projected Price to Earnings AORT (Artivion)|ENOV (Enovis Corp) - Future Price to Earnings Multiple|Future Price to Earnings Integra LifeSciences Inc. IART|ESTA - Projected Price to Earnings|Beta Bionics, Inc. - Forward P/E Multiple|Projected Price to Earnings Ratio IRADIMED CORPORATION|EMBC: Forward P/E Multiple|Price to Future Earnings Ratio TNDM|AXGN (Axogen Surgical) - Forward P/E Multiple|SI-BONE Corp (SIBN) - Market Cap to Projected Earnings|Forward P/E Multiple OFIX|Forward P/E Multiple bioventus.com (BVS)|Forward P/E Multiple KIDS (OrthoPediatrics Corp)|Forward P/E Multiple Treace Medical Concepts Inc TMCI|SRTA - Future Price to Earnings|CARL: Future Price to Earnings|RXST (RxSight, Inc.) - Projected Price to Earnings|ClearPoint Neuro Inc. - Future Price to Earnings Multiple|STXS (Stereotaxis Corporation) - Forward P/E Multiple|Projected Price to Earnings Ratio Neuronetics Inc. STIM|Future Price to Earnings Sight Sciences Inc. (SGHT)|Orchestra BioMed, Inc. (OBIO) - Forward Price to Earnings Multiple|Anika Therapeutics Inc. - Projected Price to Earnings|Forward P/E Multiple InspireMD, Inc. NSPR|Jin Medical International Ltd. - Forward P/E Multiple|Market Cap to Projected Earnings Xtant Medical XTNT|NeuroOne Medical Technologies Corporation (NMTC) - Future Price to Earnings|Price to Expected Earnings Ratio MODD (Modular Med)|MYO (Myomo Inc.) - Forward P/E Multiple|Projected Price to Earnings Envoy Medical, Inc. (COCH)|Forward P/E Multiple VVOS|NVNO - Projected Price to Earnings Ratio|Future Price to Earnings sintx.com SINT|TNON: Price to Future Earnings Ratio|LFWD: Projected Price to Earnings|autonomix.com - Market Cap to Future Earnings Ratio|INVO Bioscience, Inc. (IVF) - Future Price to Earnings|BBLG (Bone Biologics Corp.) - Future Price to Earnings|Projected Price to Earnings AXNX|Biolase Inc. (BIOL) - Market Cap to Projected Earnings|Future Price to Earnings Dynatronics Corp. (DYNT)|Forward P/E Multiple Paragon 28 (FNA)|Future Price to Earnings INVO Bioscience INVO